CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
41 hedge funds and large institutions have $151M invested in Carisma Therapeutics in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 42 → 41 (-1)
Holders
41
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$6.52M | |
| 2 | +$2.85M | |
| 3 | +$1.41M | |
| 4 |
BC
Broadfin Capital
New York
|
+$1.29M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.03M |
Top Sellers
| 1 | -$699K | |
| 2 | -$387K | |
| 3 | -$346K | |
| 4 |
BPC
Banque Pictet & Cie
Geneva 73,
Switzerland
|
-$127K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$111K |